Patent ID: 8655597

Claim:
A kit for determining expression levels in a sample from an hepatocellular carcinoma (HCC) patient of at least ten genes indicative of recurrence of HCC in the patient comprising, one or more components for determining the expression levels of said at least ten genes, wherein said one or more components are selected from the group consisting of: a DNA array chip, an oligonucleotide array chip, a protein array chip, an antibody, a plurality of probes; and a set of primers, and wherein said at least ten genes are selected from the group consisting of: (1) platelet-derived growth factor receptor alpha; (2) tumor necrosis factor alpha inducible protein A20; (3) lysosomal-associated multitransmembrane protein (LAPTm5); (4) HLA-DR alpha heavy chain; (5) rel proto-oncogene; (6) Staf50; (7) putative serine/threonine protein kinase; (8) MADS/MEF2-family transcription factor (MEF2C); (9) HUMLUCA19 Human cosmid clone LUCA19 from 3p21.3; (10) DEAD-box protein p72; (11) vimentin; and (12) KIAK0002; each as set forth in Table 2.